Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cranial Nerve Stimulator Relieves Abdominal Pain

By HospiMedica International staff writers
Posted on 17 Jun 2019
A new non-surgical device sends gentle electrical impulses into cranial nerve bundles located around the ear to reduce the abdominal pain associated with irritable bowel syndrome (IBS).

The Innovative Health Solutions (IHS; Versailles, IN, USA) IB-Stim is a percutaneous electrical nerve field stimulator (PENFS) system intended for patients 11-18 years of age with functional abdominal pain related with IBS. More...
The device is applied behind the ear, with small electrodes placed to stimulate branches of cranial nerves V, VII, IX and X, and the occipital nerves; the precise nerve locations are identified by transillumination. While the exact mechanism of action is unclear, it is hypothesized the system works by controlling activity of pain areas in the central nervous system (CNS), particularly the amygdala and spinal cord.

The prescription-only device contains a battery-powered chip that emits low-frequency electrical pulses to stimulate the cranial nerves branches continuously for five days (120 hours) per week, at which time it is replaced. Patients can use the device for up to three consecutive weeks, in conjunction with other modalities for treatment of chronic abdominal pain, including medication. IB-Stim is contraindicated for patients with hemophilia, patients with cardiac pacemakers, or those diagnosed with psoriasis vulgaris, a condition in which skin cells build up and form scales and itchy, dry patches.

“This device offers a safe option for treatment of adolescents experiencing pain from IBS through the use of mild nerve stimulation,” said Carlos Peña, PhD, director of the Office of Neurological and Physical Medicine Devices at the FDA Center for Devices and Radiological Health (CDRH). “Today’s action reflects our ongoing commitment to advancing the development of pediatric medical devices so that children and adolescents have access to safe and effective medical devices that meet their needs.”

IBS is a diagnosis of exclusion. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause. Sometimes, the painful symptoms are relieved by bowel movements. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (post-infectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.

Related Links:
Innovative Health Solutions


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.